
|Slideshows|August 11, 2017
FDA Drug and Biologic Approvals for Neurology: 2017 Midyear Review
Author(s)Natalie Timoshin
Seven new drugs were approved for treatment of neurological disorders, including Parkinson disease, multiple sclerosis, and amyotrophic lateral sclerosis.
Advertisement
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Clene to Submit Application for CNM-Au8 as Potential ALS Treatment
2
Nerivio® REN Wearable Delivers Consistent Drug-Free Relief Over Three Years, Study Shows
3
Decoding the Circuitry That Stabilizes Memory Maps in the Hippocampus
4
Overview and Design of the OCEANIC-STROKE Trial
5



































